bioanalysis-zone.com Report : Visit Site

Technical data of the bioanalysis-zone.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host bioanalysis-zone.com. Currently, hosted in United Kingdom and its service provider is UKfastnet Ltd .

the related websites

iconplc.com cisco.com amblesideonline.org amd.com samsung.com yachtsandyachting.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/5.6.33 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

bioanalysis journal | about us | contact us register login menu register login about us about bioanalysis zone contact us who we are zone leaders awards bioanalysis outstanding contribution award bioanalysis rising star award who we work with directory topics techniques automation chromatography imaging lba microsampling ms (lc–ms/ms, hrms, ims) sample preparation applications biomarkers clinical diagnostics drug development forensic immunogenicity sports drug testing toxicology molecules antibodies/adcs biosimilars large metabolites oligonucleotides small data processing & interpretation industry biopharmaceuticals collaborations & mergers regulated bioanalysis news & events events news articles articles an author's perspective ask the experts commentaries conference reports expert opinion in the zone interviews research reviews spotlights supplements a year in bioanalysis ebooks exploring microsampling panel discussion yudu the bioanalysis glossary featured improving selectivity and sensitivity of protein quantitation by lc–hr–ms/ms: determination of somatropin in rat plasma videos interviews panel discussions webinars products education zone jobs panel discussions 3 july, 2018 panel discussion: the sharing of scientific data editorials 17 july, 2018 fact or opinion? ensuring the validity of biomarker measurements news 18 july, 2018 co-development agreement for ranibizumab biosimilar and a novel biomarker test for lung cancer risk validation of biomarkers 9 july, 2018 improving selectivity and sensitivity of protein quantitation by lc–hr–ms/ms: determination of somatropin in rat plasma panel discussions 3 july, 2018 panel discussion: new technology integration in bioanalytical workflows validation of biomarkers lc–ms for biotherapeutics research: an interview with timothy olah top 5 techniques and tips for choosing old vs new technologies conference and event highlights: july to september latest webinars 3 july, 2018 0 panel discussion: the sharing of scientific data in this panel discussion we gain a 360° perspective from leading cro and pharmaceutical leaders on the sharing of scientific data. 3 july, 2018 0 panel discussion: new technology integration in bioanalytical workflows we present a rare opportunity to see experts from across the pharmaceutical and cro industries sharing perspectives on new technology integration in the field of bioanalysis. 27 june, 2018 0 custom assay development and services utilizing single molecule counting (smc™) technology single molecule counting (smc™) technology enables precise measurement of molecules at levels previously undetectable, down to the femtogram/ml levels, allowing researchers to identify new biomarkers or assist in therapeutic development with an improved view of efficacy, safety and time course studies. find out more in this video webinar from millipore sigma (ma, usa). 3 may, 2018 0 panel discussion on large molecule quantification by lc–ms available to view on demand. in this free panel discussion, our experts will provide insights into their own research with large molecules including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field. there is also an opportunity for your own questions to be answered in the live q&a. 2 may, 2018 0 new technologies and new methods for enhanced biomacromolecule separations learn about new uhplc column technologies and how to exploit them for improved characterization of biomacromolecules in our free upcoming webinar! 24 april, 2018 0 a powerful hybrid ia-lc–ms method for the determination of insulin analogues in clinical samples view webinar on demand how we can use the xevo mass spectrometer, combined with immunoaffinity extraction to provide a premium sensitivity assay for our clients and help them drive forward the development of insulin molecules and their biosimilars? – available on demand 10 april, 2018 0 metabolomics in drug development and precision medicine view webinar on demand. this webinar will highlight recent advances in metabolomics for pharmaceutical research, drug development and precision medicine. 6 february, 2018 0 bioanalysis of liposomal drugs by lc-ms/ms liposomes, used as carriers for drug delivery, encapsulate and protect the therapeutic analytes from degration. they are also capable of controlling release rate, facilitating on-target delivery and reducing toxicity for drugs. in pharmacokinetic studies for liposomal drug products, bioanalytical methods are used to determine encapsulated and free concentrations of the active substance in biological samples (e.g. read more 5 february, 2018 0 it’s all about the base: how much simpler, cleaner and faster can mixed-mode ion-exchange spe methods get? mixed-mode ion-exchange solid phase extraction (spe) is an extremely powerful sample clean-up tool when higher degrees of analyte specificity and sample cleanliness are required. however, these methods are often associated with extra method development time and complicated processes. 7 november, 2017 0 a new dimension in bioanalysis with selexion differential mobility spectrometry available to view on demand example of application areas where dms was used to compliment the lc, or even eliminate the lc separation step, will be presented in this webinar. 7 november, 2017 0 expert insights into dmpk and bioanalysis of small molecules available to view on demand this panel discussion will provide insights into the challenges, trends, developments and debates surrounding dmpk and the bioanalysis of small molecules. prev next latest news news 18 july, 2018 0 co-development agreement for ranibizumab biosimilar and a novel biomarker test for lung cancer risk find out more about the co-development agreement between xbrane and stada for a ranibizumab biosimilar, and about a novel biomarker test for establishing lung cancer risk in smokers in this week’s bioanalytical news round-up. news 11 july, 2018 0 top news in tech! read more about the top stories in new technology developments in this week’s news round-up. news 28 june, 2018 0 conference and event highlights: july to september take a look at our overview of the top events in the world of bioanalysis for july, august and september 2018. latest features validation of biomarkers 17 july, 2018 0 lc–ms for biotherapeutics research: an interview with timothy olah in this interview we talk to timothy olah (bristol-myers squibb) about his research and role as group director. he discusses his group’s responsibility for developing quantitative methods to measure novel therapeutics and biomarkers in discovery. validation of biomarkers 17 july, 2018 0 biomarker quantification: the case for the surrogate analyte approach in this editorial, robert macneill (envigo) dicusses the case for the surrogate analyte approach for biomarker validation. editorials 17 july, 2018 0 fact or opinion? ensuring the validity of biomarker measurements find out more about ensuring the validity of biomarker measurements in this editorial from liam heaney (university of loughborough, uk). drug discovery and development an overview of the gyrolab® xpand with robert durham outsourcing in the bioanalytical field: an interview with song li validated uhplc–ms/ms method for quantification of doxycycline in abdominal aortic aneurysm patients ligand-binding evolution of fit-for-purpose biomarker validations: an lba perspective 3-(4-hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysis validation of a ligand-binding assay for active protein drug quantification following the ‘free analyte qc concept’ mass spectrometry fact or opinion? ensuring the validity of biomarker measurements allena ji on the challenges of targeted biomarker quantitation by lc–ms novel adme biomarkers and hrms move new medicines to patients faster sample preparation, extraction & collection top news in tech! asthma biomarker

URL analysis for bioanalysis-zone.com

https://www.bioanalysis-zone.com/2018/02/05/its-all-about-the-base-how-much-simpler-cleaner-and-faster-can-mixed-mode-ion-exchange-spe-methods-get_waters/#respond
https://www.bioanalysis-zone.com/commentaries/
https://www.bioanalysis-zone.com/directory/companies/
https://www.bioanalysis-zone.com/login/
https://www.bioanalysis-zone.com/2018/06/26/novel-adme-biomarkers-hrms-move-new-medicines-patients-faster/
https://www.bioanalysis-zone.com/articles/ebooks/
https://www.bioanalysis-zone.com/2018/07/09/improving-selectivity-sensitivity-protein-quantitation-lc-hr-msms-determination-somatropin-rat-plasma/
https://www.bioanalysis-zone.com/category/ms-lc-msms-hrms-ims
https://www.bioanalysis-zone.com/2018/07/03/31588_bob3/
https://www.bioanalysis-zone.com/cookies-policy/
https://www.bioanalysis-zone.com/2018/05/02/new-technologies-new-methods-enhanced-biomacromolecule-separations/
https://www.bioanalysis-zone.com/2018/02/06/bioanalysis-of-liposomal-drugs-by-lc-msms_frontage/#respond
https://www.bioanalysis-zone.com/contact-us/
https://www.bioanalysis-zone.com/category/clinical
https://www.bioanalysis-zone.com/education-zone/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: BIOANALYSIS-ZONE.COM
Registry Domain ID: 1586650171_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2016-07-14T14:06:09Z
Creation Date: 2010-02-25T13:00:28Z
Registry Expiry Date: 2021-02-25T13:00:28Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok https://icann.org/epp#ok
Name Server: KIKI.NS.CLOUDFLARE.COM
Name Server: PABLO.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-09-28T11:34:26Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 123-Reg Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =bioanalysis-zone.com

  PORT 43

  TYPE domain

DOMAIN

  NAME bioanalysis-zone.com

  CHANGED 2016-07-14

  CREATED 2010-02-25

STATUS
ok https://icann.org/epp#ok

NSERVER

  KIKI.NS.CLOUDFLARE.COM 173.245.58.180

  PABLO.NS.CLOUDFLARE.COM 173.245.59.220

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .